approved_symbol,hgnc_id,gene_name_reported,source,source_count,source_evidence
ACD,25070,ACD,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",4,TRUE
ACTRT1,24027,ACTRT1,"Genodermatoses with malignancies (id=201, version=1.9) | Multiple monogenic benign skin tumours (id=558, version=2.2)",2,FALSE
ADM,259,ADM,"GI tract tumours (id=254, version=1.22)",1,FALSE
AIP,358,AIP,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Multiple endocrine tumours (id=36, version=1.14) | Parathyroid Cancer (id=86, version=1.4)",4,TRUE
AKT1,391,AKT1,"Childhood solid tumours (id=243, version=4.2) | Genodermatoses with malignancies (id=201, version=1.9)",2,FALSE
ALK,427,ALK,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
ANKRD26,29186,ANKRD26,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
APC,583,APC,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Brain cancer pertinent cancer susceptibility (id=166, version=1.2) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Colorectal cancer pertinent cancer susceptibility (id=244, version=1.0) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | GI tract tumours (id=254, version=1.22) | Inherited non-medullary thyroid cancer (id=171, version=1.5) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128)",13,TRUE
AR,644,AR,"Familial breast cancer (id=158, version=1.18) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1)",2,FALSE
ASXL1,18318,ASXL1,"Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",2,TRUE
ATM,795,ATM,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Brain cancer pertinent cancer susceptibility (id=166, version=1.2) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial breast cancer (id=158, version=1.18) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Inherited breast cancer and ovarian cancer (id=635, version=2.6) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Inherited prostate cancer (id=1223, version=1.2) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128)",14,TRUE
ATR,882,ATR,"Sarcoma susceptibility (id=734, version=1.73)",1,TRUE
ATRIP,33499,ATRIP,"Breast cancer pertinent cancer susceptibility (id=55, version=2.1) | Familial breast cancer (id=158, version=1.18)",2,FALSE
AXIN2,904,AXIN2,"Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4)",1,TRUE
BAP1,950,BAP1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Inherited renal cancer (id=521, version=1.24) | Melanoma pertinent cancer susceptibility (id=133, version=1.0) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Renal cancer (id=3278, version=0.4)",6,TRUE
BARD1,952,BARD1,"Familial breast cancer (id=158, version=1.18) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1)",2,FALSE
BLM,1058,BLM,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",7,TRUE
BMPR1A,1076,BMPR1A,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Colorectal cancer pertinent cancer susceptibility (id=244, version=1.0) | GI tract tumours (id=254, version=1.22) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4) | Cancer Predisposition_Paediatric (id=152, version=0.128)",8,TRUE
BRAF,1097,BRAF,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Inherited non-medullary thyroid cancer (id=171, version=1.5) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Cancer Predisposition_Paediatric (id=152, version=0.128)",6,TRUE
BRCA1,1100,BRCA1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Breast cancer pertinent cancer susceptibility (id=55, version=2.1) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial breast cancer (id=158, version=1.18) | Familial prostate cancer (id=318, version=1.3) | GI tract tumours (id=254, version=1.22) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Inherited breast cancer and ovarian cancer (id=635, version=2.6) | Inherited non-medullary thyroid cancer (id=171, version=1.5) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Inherited pancreatic cancer (id=524, version=2.1) | Inherited prostate cancer (id=1223, version=1.2) | Ovarian cancer pertinent cancer susceptibility (id=117, version=2.1) | Cancer Predisposition_Paediatric (id=152, version=0.128)",17,TRUE
BRCA2,1101,BRCA2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Breast cancer pertinent cancer susceptibility (id=55, version=2.1) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial breast cancer (id=158, version=1.18) | Familial prostate cancer (id=318, version=1.3) | GI tract tumours (id=254, version=1.22) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Inherited breast cancer and ovarian cancer (id=635, version=2.6) | Inherited non-medullary thyroid cancer (id=171, version=1.5) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Inherited pancreatic cancer (id=524, version=2.1) | Inherited prostate cancer (id=1223, version=1.2) | Ovarian cancer pertinent cancer susceptibility (id=117, version=2.1) | Prostate cancer pertinent cancer susceptibility (id=17, version=1.2) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",20,TRUE
BRIP1,20473,BRIP1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial breast cancer (id=158, version=1.18) | Familial prostate cancer (id=318, version=1.3) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Head and neck cancer pertinent cancer susceptibility (id=115, version=1.0) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Ovarian cancer pertinent cancer susceptibility (id=117, version=2.1) | Cancer Predisposition_Paediatric (id=152, version=0.128)",12,TRUE
BUB1B,1149,BUB1B,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial rhabdomyosarcoma (id=290, version=1.5) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",7,TRUE
CASR,1514,CASR,"Parathyroid Cancer (id=86, version=1.4)",1,FALSE
CBL,1541,CBL,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Cancer Predisposition_Paediatric (id=152, version=0.128)",6,TRUE
CDC73,16783,CDC73,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Multiple endocrine tumours (id=36, version=1.14) | Parathyroid Cancer (id=86, version=1.4) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",8,TRUE
CDH1,1748,CDH1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Breast cancer pertinent cancer susceptibility (id=55, version=2.1) | CDH1-related cancer syndrome (id=1221, version=1.1) | Familial breast cancer (id=158, version=1.18) | GI tract tumours (id=254, version=1.22) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Cancer Predisposition_Paediatric (id=152, version=0.128)",8,TRUE
CDK4,1773,CDK4,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Inherited pancreatic cancer (id=524, version=2.1) | Melanoma pertinent cancer susceptibility (id=133, version=1.0) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Cancer Predisposition_Paediatric (id=152, version=0.128)",6,TRUE
CDKN1B,1785,CDKN1B,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Multiple endocrine tumours (id=36, version=1.14) | Neuroendocrine cancer pertinent cancer susceptibility (id=183, version=1.4) | Parathyroid Cancer (id=86, version=1.4) | Thyroid cancer pertinent cancer susceptibility (id=421, version=1.3)",7,TRUE
CDKN1C,1786,CDKN1C,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial rhabdomyosarcoma (id=290, version=1.5) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Wilms tumour with features suggestive of predisposition (id=1108, version=1.1) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",8,TRUE
CDKN2A,1787,CDKN2A,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | GI tract tumours (id=254, version=1.22) | Inherited pancreatic cancer (id=524, version=2.1) | Melanoma pertinent cancer susceptibility (id=133, version=1.0) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Cancer Predisposition_Paediatric (id=152, version=0.128)",7,TRUE
CDKN2B,1788,CDKN2B,"Inherited renal cancer (id=521, version=1.24)",1,TRUE
CEBPA,1833,CEBPA,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Cancer Predisposition_Paediatric (id=152, version=0.128)",3,TRUE
CHEK2,16627,CHEK2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Familial breast cancer (id=158, version=1.18) | Familial prostate cancer (id=318, version=1.3) | GI tract tumours (id=254, version=1.22) | Inherited breast cancer and ovarian cancer (id=635, version=2.6) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Inherited prostate cancer (id=1223, version=1.2) | Cancer Predisposition_Paediatric (id=152, version=0.128)",9,TRUE
CIB1,16920,CIB1,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
CREBBP,2348,CREBBP,"Familial rhabdomyosarcoma (id=290, version=1.5) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73)",3,FALSE
CSF3R,2439,CSF3R,"Haematological malignancies cancer susceptibility (id=59, version=4.2)",1,FALSE
CTC1,26169,CTC1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",4,TRUE
CTCF,13723,CTCF,"Wilms Tumour Predisposition (id=252, version=0.39)",1,FALSE
CTNNB1,2514,CTNNB1,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
CTR9,16850,CTR9,"Childhood solid tumours (id=243, version=4.2) | Wilms tumour with features suggestive of predisposition (id=1108, version=1.1) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",4,TRUE
CYLD,2584,CYLD,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,TRUE
DDB2,2718,DDB2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
DDX41,18674,DDX41,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
DGCR8,2847,DGCR8,"Adult solid tumours cancer susceptibility (id=245, version=2.24)",1,FALSE
DICER1,17098,DICER1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial rhabdomyosarcoma (id=290, version=1.5) | Inherited non-medullary thyroid cancer (id=171, version=1.5) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",10,TRUE
DIRAS3,687,DIRAS3,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,FALSE
DIS3L2,28648,DIS3L2,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",4,TRUE
DKC1,2890,DKC1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",4,TRUE
DLST,2911,DLST,"Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1)",1,TRUE
DNAJC21,27030,DNAJC21,"Haematological malignancies cancer susceptibility (id=59, version=4.2)",1,TRUE
DOCK8,19191,DOCK8,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
ELAC2,14198,ELAC2,"Familial prostate cancer (id=318, version=1.3)",1,FALSE
ELANE,3309,ELANE,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
ELOC,11617,ELOC,"Inherited renal cancer (id=521, version=1.24)",1,FALSE
ELP1,5959,ELP1,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128)",3,TRUE
ENG,3349,ENG,"GI tract tumours (id=254, version=1.22)",1,FALSE
EPAS1,3374,EPAS1,"Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1)",1,TRUE
EPCAM,11529,EPCAM,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Familial breast cancer (id=158, version=1.18) | GI tract tumours (id=254, version=1.22) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4) | Cancer Predisposition_Paediatric (id=152, version=0.128)",7,TRUE
ERCC1,3433,ERCC1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
ERCC2,3434,ERCC2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128)",5,TRUE
ERCC3,3435,ERCC3,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
ERCC4,3436,ERCC4,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Cancer Predisposition_Paediatric (id=152, version=0.128)",6,TRUE
ERCC5,3437,ERCC5,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
ERCC6L2,26922,ERCC6L2,"Haematological malignancies cancer susceptibility (id=59, version=4.2)",1,TRUE
ESR1,3467,ESR1,"Familial breast cancer (id=158, version=1.18) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1)",2,FALSE
ETV6,3495,ETV6,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
EXT1,3512,EXT1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Sarcoma (id=3281, version=0.3)",5,TRUE
EXT2,3513,EXT2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Sarcoma (id=3281, version=0.3)",5,TRUE
EZH2,3527,EZH2,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24)",2,TRUE
FANCA,3582,FANCA,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Head and neck cancer pertinent cancer susceptibility (id=115, version=1.0) | Cancer Predisposition_Paediatric (id=152, version=0.128)",7,TRUE
FANCB,3583,FANCB,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Head and neck cancer pertinent cancer susceptibility (id=115, version=1.0)",6,TRUE
FANCC,3584,FANCC,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Head and neck cancer pertinent cancer susceptibility (id=115, version=1.0) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128)",8,TRUE
FANCD2,3585,FANCD2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Head and neck cancer pertinent cancer susceptibility (id=115, version=1.0) | Cancer Predisposition_Paediatric (id=152, version=0.128)",7,TRUE
FANCE,3586,FANCE,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Head and neck cancer pertinent cancer susceptibility (id=115, version=1.0) | Cancer Predisposition_Paediatric (id=152, version=0.128)",7,TRUE
FANCF,3587,FANCF,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Head and neck cancer pertinent cancer susceptibility (id=115, version=1.0) | Cancer Predisposition_Paediatric (id=152, version=0.128)",7,TRUE
FANCG,3588,FANCG,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Head and neck cancer pertinent cancer susceptibility (id=115, version=1.0) | Cancer Predisposition_Paediatric (id=152, version=0.128)",7,TRUE
FANCI,25568,FANCI,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Head and neck cancer pertinent cancer susceptibility (id=115, version=1.0) | Cancer Predisposition_Paediatric (id=152, version=0.128)",7,TRUE
FANCL,20748,FANCL,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Head and neck cancer pertinent cancer susceptibility (id=115, version=1.0) | Cancer Predisposition_Paediatric (id=152, version=0.128)",7,TRUE
FANCM,23168,FANCM,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Head and neck cancer pertinent cancer susceptibility (id=115, version=1.0) | Cancer Predisposition_Paediatric (id=152, version=0.128)",6,TRUE
FAS,11920,FAS,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
FBXW7,16712,FBXW7,"Childhood solid tumours (id=243, version=4.2) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",3,TRUE
FGF23,3680,FGF23,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
FGFR2,3689,FGFR2,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
FGFR3,3690,FGFR3,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
FH,3700,FH,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Endometrial cancer pertinent cancer susceptibility (id=271, version=1.0) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1) | Inherited renal cancer (id=521, version=1.24) | Neuroendocrine cancer pertinent cancer susceptibility (id=183, version=1.4) | Renal cancer pertinent cancer susceptibility (id=154, version=1.2) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Renal cancer (id=3278, version=0.4)",12,TRUE
FLCN,27310,FLCN,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Inherited renal cancer (id=521, version=1.24) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Renal cancer pertinent cancer susceptibility (id=154, version=1.2) | Renal cancer (id=3278, version=0.4)",6,TRUE
FOXE1,3806,FOXE1,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,TRUE
FOXO1,3819,FOXO1,"Familial rhabdomyosarcoma (id=290, version=1.5) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73)",3,FALSE
FOXO3,3821,FOXO3,"GI tract tumours (id=254, version=1.22)",1,FALSE
GALNT3,4125,GALNT3,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
GATA1,4170,GATA1,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
GATA2,4171,GATA2,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Cancer Predisposition_Paediatric (id=152, version=0.128)",3,TRUE
GBA1,4177,GBA,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
GDNF,4232,GDNF,"Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11)",1,FALSE
GLA,4296,GLA,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
GNAS,4392,GNAS,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,FALSE
GPC3,4451,GPC3,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",4,TRUE
GPC4,4452,GPC4,"Wilms Tumour Predisposition (id=252, version=0.39)",1,FALSE
GPR161,23694,GPR161,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128)",3,TRUE
GREM1,2001,GREM1,"GI tract tumours (id=254, version=1.22) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4)",2,TRUE
H19,4713,H19,"Childhood solid tumours (id=243, version=4.2)",1,FALSE
HABP2,4798,HABP2,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,FALSE
HAX1,16915,HAX1,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
HOXB13,5112,HOXB13,"Familial prostate cancer (id=318, version=1.3)",1,FALSE
HPLH1,23824,HPLH1,"Haematological malignancies cancer susceptibility (id=59, version=4.2)",1,FALSE
HRAS,5173,HRAS,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial rhabdomyosarcoma (id=290, version=1.5) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128)",8,TRUE
IGF2,5466,IGF2,"Childhood solid tumours (id=243, version=4.2)",1,FALSE
IKZF1,13176,IKZF1,"Haematological malignancies cancer susceptibility (id=59, version=4.2)",1,TRUE
IRF4,6119,IRF4,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
ITK,6171,ITK,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
JAK2,6192,JAK2,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
KCNQ1OT1,6295,KCNQ1OT1,"Childhood solid tumours (id=243, version=4.2)",1,FALSE
KDM3B,1337,KDM3B,"Childhood solid tumours (id=243, version=4.2) | Cancer Predisposition_Paediatric (id=152, version=0.128)",2,TRUE
KIF1B,16636,KIF1B,"Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11)",1,FALSE
KISS1R,4510,KISS1R,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,FALSE
KIT,6342,KIT,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73)",4,TRUE
KLLN,37212,KLLN,"Childhood solid tumours (id=243, version=4.2) | Genodermatoses with malignancies (id=201, version=1.9)",2,FALSE
KRAS,6407,KRAS,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial rhabdomyosarcoma (id=290, version=1.5) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128)",8,TRUE
KRT17,6427,KRT17,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
LEF1,6551,LEF1,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
LEMD3,28887,LEMD3,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,TRUE
LIG4,6601,LIG4,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
LZTR1,6742,LZTR1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14)",3,TRUE
MAD2L2,6764,MAD2L2,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
MAP2K1,6840,MAP2K1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
MAP2K2,6842,MAP2K2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
MAX,6913,MAX,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1) | Multiple endocrine tumours (id=36, version=1.14) | Neuroendocrine cancer pertinent cancer susceptibility (id=183, version=1.4) | Cancer Predisposition_Paediatric (id=152, version=0.128)",8,TRUE
MBD4,6919,MBD4,"GI tract tumours (id=254, version=1.22) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4)",3,TRUE
MC1R,6929,MC1R,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
MDH2,6971,MDH2,"Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1)",2,TRUE
MEN1,7010,MEN1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Inherited non-medullary thyroid cancer (id=171, version=1.5) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1) | Multiple endocrine tumours (id=36, version=1.14) | Neuroendocrine cancer pertinent cancer susceptibility (id=183, version=1.4) | Parathyroid Cancer (id=86, version=1.4) | Cancer Predisposition_Paediatric (id=152, version=0.128)",12,TRUE
MET,7029,MET,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Inherited renal cancer (id=521, version=1.24) | Renal cancer pertinent cancer susceptibility (id=154, version=1.2) | Renal cancer (id=3278, version=0.4)",5,TRUE
MINPP1,7102,MINPP1,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,FALSE
MITF,7105,MITF,"Inherited renal cancer (id=521, version=1.24)",1,TRUE
MLH1,7127,MLH1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Bladder cancer pertinent cancer susceptibility (id=208, version=1.1) | Brain cancer pertinent cancer susceptibility (id=166, version=1.2) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Colorectal cancer pertinent cancer susceptibility (id=244, version=1.0) | Endometrial cancer pertinent cancer susceptibility (id=271, version=1.0) | Familial breast cancer (id=158, version=1.18) | Familial rhabdomyosarcoma (id=290, version=1.5) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Genodermatoses with malignancies (id=201, version=1.9) | GI tract tumours (id=254, version=1.22) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Inherited pancreatic cancer (id=524, version=2.1) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4) | Inherited prostate cancer (id=1223, version=1.2) | Inherited renal cancer (id=521, version=1.24) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Ovarian cancer pertinent cancer susceptibility (id=117, version=2.1) | Prostate cancer pertinent cancer susceptibility (id=17, version=1.2) | Renal cancer pertinent cancer susceptibility (id=154, version=1.2) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Upper gastrointestinal cancer pertinent cancer susceptibility (id=273, version=1.0) | Cancer Predisposition_Paediatric (id=152, version=0.128)",28,TRUE
MSH2,7325,MSH2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Bladder cancer pertinent cancer susceptibility (id=208, version=1.1) | Brain cancer pertinent cancer susceptibility (id=166, version=1.2) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Colorectal cancer pertinent cancer susceptibility (id=244, version=1.0) | Endometrial cancer pertinent cancer susceptibility (id=271, version=1.0) | Familial breast cancer (id=158, version=1.18) | Familial prostate cancer (id=318, version=1.3) | Familial rhabdomyosarcoma (id=290, version=1.5) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Genodermatoses with malignancies (id=201, version=1.9) | GI tract tumours (id=254, version=1.22) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Inherited non-medullary thyroid cancer (id=171, version=1.5) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Inherited pancreatic cancer (id=524, version=2.1) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4) | Inherited prostate cancer (id=1223, version=1.2) | Inherited renal cancer (id=521, version=1.24) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Ovarian cancer pertinent cancer susceptibility (id=117, version=2.1) | Prostate cancer pertinent cancer susceptibility (id=17, version=1.2) | Renal cancer pertinent cancer susceptibility (id=154, version=1.2) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Upper gastrointestinal cancer pertinent cancer susceptibility (id=273, version=1.0) | Cancer Predisposition_Paediatric (id=152, version=0.128)",30,TRUE
MSH3,7326,MSH3,"GI tract tumours (id=254, version=1.22) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4)",2,TRUE
MSH5,7328,MSH5,"Familial prostate cancer (id=318, version=1.3)",1,FALSE
MSH6,7329,MSH6,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Bladder cancer pertinent cancer susceptibility (id=208, version=1.1) | Brain cancer pertinent cancer susceptibility (id=166, version=1.2) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Colorectal cancer pertinent cancer susceptibility (id=244, version=1.0) | Endometrial cancer pertinent cancer susceptibility (id=271, version=1.0) | Familial breast cancer (id=158, version=1.18) | Familial prostate cancer (id=318, version=1.3) | Familial rhabdomyosarcoma (id=290, version=1.5) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Genodermatoses with malignancies (id=201, version=1.9) | GI tract tumours (id=254, version=1.22) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Inherited non-medullary thyroid cancer (id=171, version=1.5) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Inherited pancreatic cancer (id=524, version=2.1) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4) | Inherited prostate cancer (id=1223, version=1.2) | Inherited renal cancer (id=521, version=1.24) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Ovarian cancer pertinent cancer susceptibility (id=117, version=2.1) | Prostate cancer pertinent cancer susceptibility (id=17, version=1.2) | Renal cancer pertinent cancer susceptibility (id=154, version=1.2) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Upper gastrointestinal cancer pertinent cancer susceptibility (id=273, version=1.0) | Cancer Predisposition_Paediatric (id=152, version=0.128)",30,TRUE
MSR1,7376,MSR1,"Familial prostate cancer (id=318, version=1.3)",1,FALSE
MTAP,7413,MTAP,"Childhood solid tumours (id=243, version=4.2) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73)",3,TRUE
MUTYH,7527,MUTYH,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Colorectal cancer pertinent cancer susceptibility (id=244, version=1.0) | Familial breast cancer (id=158, version=1.18) | GI tract tumours (id=254, version=1.22) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4) | Cancer Predisposition_Paediatric (id=152, version=0.128)",8,TRUE
NAF1,25126,NAF1,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
NBN,7652,NBN,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial breast cancer (id=158, version=1.18) | Familial rhabdomyosarcoma (id=290, version=1.5) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128)",11,TRUE
NDUFA13,17194,NDUFA13,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,FALSE
NF1,7765,NF1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial rhabdomyosarcoma (id=290, version=1.5) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128)",14,TRUE
NF2,7773,NF2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Cancer Predisposition_Paediatric (id=152, version=0.128)",6,TRUE
NFIX,7788,NFIX,"Childhood solid tumours (id=243, version=4.2)",1,FALSE
NHP2,14377,NHP2,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Cancer Predisposition_Paediatric (id=152, version=0.128)",5,TRUE
NKX2-1,11825,NKX2-1,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,FALSE
NOP10,14378,NOP10,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Cancer Predisposition_Paediatric (id=152, version=0.128)",6,TRUE
NOTCH3,7883,NOTCH3,"Childhood solid tumours (id=243, version=4.2) | Multiple monogenic benign skin tumours (id=558, version=2.2)",2,TRUE
NRAS,7989,NRAS,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Cancer Predisposition_Paediatric (id=152, version=0.128)",5,TRUE
NSD1,14234,NSD1,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24)",2,TRUE
NTHL1,8028,NTHL1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Colorectal cancer pertinent cancer susceptibility (id=244, version=1.0) | GI tract tumours (id=254, version=1.22) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4)",5,TRUE
NTRK1,8031,NTRK1,"Multiple endocrine tumours (id=36, version=1.14)",1,FALSE
NYNRIN,20165,NYNRIN,"Childhood solid tumours (id=243, version=4.2) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",3,TRUE
PALB2,26144,PALB2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Breast cancer pertinent cancer susceptibility (id=55, version=2.1) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial breast cancer (id=158, version=1.18) | Familial prostate cancer (id=318, version=1.3) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Inherited breast cancer and ovarian cancer (id=635, version=2.6) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Inherited pancreatic cancer (id=524, version=2.1) | Inherited prostate cancer (id=1223, version=1.2) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",16,TRUE
PARN,8609,PARN,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",4,TRUE
PAX3,8617,PAX3,"Familial rhabdomyosarcoma (id=290, version=1.5) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73)",3,FALSE
PAX5,8619,PAX5,"Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
PAX6,8620,PAX6,"Childhood solid tumours (id=243, version=4.2)",1,FALSE
PAX7,8621,PAX7,"Familial rhabdomyosarcoma (id=290, version=1.5) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73)",3,FALSE
PDGFRA,8803,PDGFRA,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73)",6,TRUE
PDGFRB,8804,PDGFRB,"Childhood solid tumours (id=243, version=4.2) | Multiple monogenic benign skin tumours (id=558, version=2.2)",2,TRUE
PHOX2B,9143,PHOX2B,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
PIK3CA,8975,PIK3CA,"Childhood solid tumours (id=243, version=4.2) | Genodermatoses with malignancies (id=201, version=1.9) | Inherited non-medullary thyroid cancer (id=171, version=1.5) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",6,TRUE
PMS2,9122,PMS2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Bladder cancer pertinent cancer susceptibility (id=208, version=1.1) | Brain cancer pertinent cancer susceptibility (id=166, version=1.2) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Colorectal cancer pertinent cancer susceptibility (id=244, version=1.0) | Endometrial cancer pertinent cancer susceptibility (id=271, version=1.0) | Familial breast cancer (id=158, version=1.18) | Familial rhabdomyosarcoma (id=290, version=1.5) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | GI tract tumours (id=254, version=1.22) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Inherited pancreatic cancer (id=524, version=2.1) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4) | Inherited renal cancer (id=521, version=1.24) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Ovarian cancer pertinent cancer susceptibility (id=117, version=2.1) | Prostate cancer pertinent cancer susceptibility (id=17, version=1.2) | Renal cancer pertinent cancer susceptibility (id=154, version=1.2) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Upper gastrointestinal cancer pertinent cancer susceptibility (id=273, version=1.0) | Cancer Predisposition_Paediatric (id=152, version=0.128)",26,TRUE
POLD1,9175,POLD1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Colorectal cancer pertinent cancer susceptibility (id=244, version=1.0) | GI tract tumours (id=254, version=1.22) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4)",5,TRUE
POLE,9177,POLE,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Colorectal cancer pertinent cancer susceptibility (id=244, version=1.0) | GI tract tumours (id=254, version=1.22) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4)",5,TRUE
POLH,9181,POLH,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2)",2,TRUE
PORCN,17652,PORCN,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
PPM1D,9277,PPM1D,"Familial breast cancer (id=158, version=1.18) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1)",2,FALSE
PPP1CB,9282,PPP1CB,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2)",2,TRUE
PRDM10,13995,PRDM10,"Inherited renal cancer (id=521, version=1.24) | Multiple monogenic benign skin tumours (id=558, version=2.2)",2,FALSE
PRF1,9360,PRF1,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
PRKAR1A,9388,PRKAR1A,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Inherited non-medullary thyroid cancer (id=171, version=1.5) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1) | Multiple endocrine tumours (id=36, version=1.14) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Parathyroid Cancer (id=86, version=1.4) | Thyroid cancer pertinent cancer susceptibility (id=421, version=1.3) | Cancer Predisposition_Paediatric (id=152, version=0.128)",10,TRUE
PRSS1,9475,PRSS1,"Inherited pancreatic cancer (id=524, version=2.1)",1,TRUE
PTCH1,9585,PTCH1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Genodermatoses with malignancies (id=201, version=1.9) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Cancer Predisposition_Paediatric (id=152, version=0.128)",8,TRUE
PTCH2,9586,PTCH2,"Genodermatoses with malignancies (id=201, version=1.9) | Multiple monogenic benign skin tumours (id=558, version=2.2)",2,TRUE
PTCSC1,37127,PTCSC1,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,FALSE
PTCSC3,43959,PTCSC3,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,FALSE
PTEN,9588,PTEN,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Breast cancer pertinent cancer susceptibility (id=55, version=2.1) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Colorectal cancer pertinent cancer susceptibility (id=244, version=1.0) | Endometrial cancer pertinent cancer susceptibility (id=271, version=1.0) | Familial breast cancer (id=158, version=1.18) | Familial prostate cancer (id=318, version=1.3) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Genodermatoses with malignancies (id=201, version=1.9) | GI tract tumours (id=254, version=1.22) | Inherited non-medullary thyroid cancer (id=171, version=1.5) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4) | Inherited renal cancer (id=521, version=1.24) | Multiple endocrine tumours (id=36, version=1.14) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Renal cancer pertinent cancer susceptibility (id=154, version=1.2) | Sarcoma susceptibility (id=734, version=1.73) | Thyroid cancer pertinent cancer susceptibility (id=421, version=1.3) | Cancer Predisposition_Paediatric (id=152, version=0.128)",23,TRUE
PTPN11,9644,PTPN11,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Cancer Predisposition_Paediatric (id=152, version=0.128)",6,TRUE
PTPN12,9645,PTPN12,"GI tract tumours (id=254, version=1.22)",1,FALSE
RABL3,18072,RABL3,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Inherited pancreatic cancer (id=524, version=2.1)",2,FALSE
RAD21,9811,RAD21,"Haematological malignancies cancer susceptibility (id=59, version=4.2)",1,TRUE
RAD51,9817,RAD51,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RAD51C,9820,RAD51C,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial breast cancer (id=158, version=1.18) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Inherited breast cancer and ovarian cancer (id=635, version=2.6) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Ovarian cancer pertinent cancer susceptibility (id=117, version=2.1) | Cancer Predisposition_Paediatric (id=152, version=0.128)",11,TRUE
RAD51D,9823,RAD51D,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Familial breast cancer (id=158, version=1.18) | Inherited breast cancer and ovarian cancer (id=635, version=2.6) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Ovarian cancer pertinent cancer susceptibility (id=117, version=2.1)",6,TRUE
RAD54L,9826,RAD54L,"Familial breast cancer (id=158, version=1.18) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1)",2,FALSE
RAF1,9829,RAF1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
RB1,9884,RB1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial rhabdomyosarcoma (id=290, version=1.5) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Sarcoma (id=3281, version=0.3)",9,TRUE
RECQL4,9949,RECQL4,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128)",5,TRUE
REST,9966,REST,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Wilms tumour with features suggestive of predisposition (id=1108, version=1.1) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",5,TRUE
RET,9967,RET,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1) | Multiple endocrine tumours (id=36, version=1.14) | Neuroendocrine cancer pertinent cancer susceptibility (id=183, version=1.4) | Parathyroid Cancer (id=86, version=1.4) | Thyroid cancer pertinent cancer susceptibility (id=421, version=1.3) | Cancer Predisposition_Paediatric (id=152, version=0.128)",11,TRUE
RIT1,10023,RIT1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2)",2,TRUE
RMRP,10031,RMRP,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RNASEL,10050,RNASEL,"Familial prostate cancer (id=318, version=1.3)",1,FALSE
RNF43,18505,RNF43,"GI tract tumours (id=254, version=1.22) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4)",2,TRUE
RPL11,10301,RPL11,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPL15,10306,RPL15,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPL23,10316,RPL23,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPL26,10327,RPL26,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPL27,10328,RPL27,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPL31,10334,RPL31,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPL35A,10345,RPL35A,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPL36,13631,RPL36,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPL5,10360,RPL5,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPS10,10383,RPS10,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPS15,10388,RPS15,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPS17,10397,RPS17,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPS19,10402,RPS19,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPS24,10411,RPS24,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPS26,10414,RPS26,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPS27,10416,RPS27,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPS27A,10417,RPS27A,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPS28,10418,RPS28,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPS29,10419,RPS29,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RPS7,10440,RPS7,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
RRAS2,17271,RRAS2,"Familial breast cancer (id=158, version=1.18) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1)",2,FALSE
RTEL1,15888,RTEL1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",4,TRUE
RUNX1,10471,RUNX1,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Cancer Predisposition_Paediatric (id=152, version=0.128)",3,TRUE
SAMD9,1348,SAMD9,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
SAMD9L,1349,SAMD9L,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
SASH1,19182,SASH1,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
SBDS,19440,SBDS,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
SDHA,10680,SDHA,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1) | Neuroendocrine cancer pertinent cancer susceptibility (id=183, version=1.4) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128)",8,TRUE
SDHAF2,26034,SDHAF2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1) | Multiple endocrine tumours (id=36, version=1.14) | Neuroendocrine cancer pertinent cancer susceptibility (id=183, version=1.4) | Cancer Predisposition_Paediatric (id=152, version=0.128)",7,TRUE
SDHB,10681,SDHB,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Genodermatoses with malignancies (id=201, version=1.9) | Inherited non-medullary thyroid cancer (id=171, version=1.5) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1) | Inherited renal cancer (id=521, version=1.24) | Multiple endocrine tumours (id=36, version=1.14) | Neuroendocrine cancer pertinent cancer susceptibility (id=183, version=1.4) | Renal cancer pertinent cancer susceptibility (id=154, version=1.2) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Renal cancer (id=3278, version=0.4)",15,TRUE
SDHC,10682,SDHC,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1) | Inherited renal cancer (id=521, version=1.24) | Multiple endocrine tumours (id=36, version=1.14) | Neuroendocrine cancer pertinent cancer susceptibility (id=183, version=1.4) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Renal cancer (id=3278, version=0.4)",11,TRUE
SDHD,10683,SDHD,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Genodermatoses with malignancies (id=201, version=1.9) | Inherited non-medullary thyroid cancer (id=171, version=1.5) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1) | Inherited renal cancer (id=521, version=1.24) | Multiple endocrine tumours (id=36, version=1.14) | Neuroendocrine cancer pertinent cancer susceptibility (id=183, version=1.4) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Renal cancer (id=3278, version=0.4)",14,TRUE
SEC23B,10702,SEC23B,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,TRUE
SH2B3,29605,SH2B3,"Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
SH2D1A,10820,SH2D1A,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
SHOC2,15454,SHOC2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
SLC25A11,10981,SLC25A11,"Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1)",1,TRUE
SLC26A3,3018,SLC26A3,"GI tract tumours (id=254, version=1.22)",1,FALSE
SLC5A5,11040,SLC5A5,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,TRUE
SLX4,23845,SLX4,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Head and neck cancer pertinent cancer susceptibility (id=115, version=1.0)",6,TRUE
SMAD4,6770,SMAD4,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Colorectal cancer pertinent cancer susceptibility (id=244, version=1.0) | GI tract tumours (id=254, version=1.22) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4) | Cancer Predisposition_Paediatric (id=152, version=0.128)",8,TRUE
SMAD9,6774,SMAD9,"GI tract tumours (id=254, version=1.22)",1,FALSE
SMARCA4,11100,SMARCA4,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Rhabdoid tumour predisposition (id=600, version=1.6) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128)",7,TRUE
SMARCB1,11103,SMARCB1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Rhabdoid tumour predisposition (id=600, version=1.6) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128)",8,TRUE
SMARCE1,11109,SMARCE1,"Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14)",1,TRUE
SOS1,11187,SOS1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
SOS2,11188,SOS2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2)",2,TRUE
SPOP,11254,SPOP,"Familial prostate cancer (id=318, version=1.3)",1,FALSE
SPRED1,20249,SPRED1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2)",2,FALSE
SQSTM1,11280,SQSTM1,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73)",4,TRUE
SRC,11283,SRC,"GI tract tumours (id=254, version=1.22)",1,FALSE
SRGAP1,17382,SRGAP1,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,FALSE
SRRM2,16639,SRRM2,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,FALSE
STAT3,11364,STAT3,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
STK11,11389,STK11,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Colorectal cancer pertinent cancer susceptibility (id=244, version=1.0) | Familial breast cancer (id=158, version=1.18) | GI tract tumours (id=254, version=1.22) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Inherited pancreatic cancer (id=524, version=2.1) | Inherited polyposis and early onset colorectal cancer - germline testing (id=504, version=2.4) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Cancer Predisposition_Paediatric (id=152, version=0.128)",12,TRUE
STN1,26200,STN1,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
STX11,11429,STX11,"Haematological malignancies cancer susceptibility (id=59, version=4.2)",1,TRUE
STXBP2,11445,STXBP2,"Haematological malignancies cancer susceptibility (id=59, version=4.2)",1,TRUE
SUFU,16466,SUFU,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Genodermatoses with malignancies (id=201, version=1.9) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Cancer Predisposition_Paediatric (id=152, version=0.128)",8,TRUE
TBXT,11515,T,"Childhood solid tumours (id=243, version=4.2) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73)",3,TRUE
TERC,11727,TERC,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",4,TRUE
TERT,11730,TERT,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Cancer Predisposition_Paediatric (id=152, version=0.128)",6,TRUE
TG,11764,TG,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,FALSE
TINF2,11824,TINF2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",4,TRUE
TMC6,18021,TMC6,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
TMC8,20474,TMC8,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
TMEM127,26038,TMEM127,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1) | Inherited renal cancer (id=521, version=1.24) | Multiple endocrine tumours (id=36, version=1.14) | Neuroendocrine cancer pertinent cancer susceptibility (id=183, version=1.4) | Cancer Predisposition_Paediatric (id=152, version=0.128)",8,TRUE
TNFRSF11A,11908,TNFRSF11A,"Childhood solid tumours (id=243, version=4.2) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73)",3,FALSE
TP53,11998,TP53,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Brain cancer pertinent cancer susceptibility (id=166, version=1.2) | Breast cancer pertinent cancer susceptibility (id=55, version=2.1) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial breast cancer (id=158, version=1.18) | Familial rhabdomyosarcoma (id=290, version=1.5) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | GI tract tumours (id=254, version=1.22) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Multiple endocrine tumours (id=36, version=1.14) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Sarcoma (id=3281, version=0.3) | Wilms Tumour Predisposition (id=252, version=0.39)",20,TRUE
TRIM28,16384,TRIM28,"Childhood solid tumours (id=243, version=4.2) | Wilms tumour with features suggestive of predisposition (id=1108, version=1.1) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",4,TRUE
TRIM37,7523,TRIM37,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",4,TRUE
TRIP13,12307,TRIP13,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128)",3,TRUE
TSC1,12362,TSC1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Renal cancer (id=3278, version=0.4)",7,TRUE
TSC2,12363,TSC2,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Multiple monogenic benign skin tumours (id=558, version=2.2) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Renal cancer (id=3278, version=0.4)",7,TRUE
TSR2,25455,TSR2,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
UBA2,30661,UBA2,"Haematological malignancies cancer susceptibility (id=59, version=4.2)",1,FALSE
UBE2T,25009,UBE2T,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
UNC13D,23147,UNC13D,"Haematological malignancies cancer susceptibility (id=59, version=4.2)",1,TRUE
VDR,12679,VDR,"Multiple monogenic benign skin tumours (id=558, version=2.2)",1,FALSE
VHL,12687,VHL,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial Tumours Syndromes of the central & peripheral Nervous system (id=167, version=1.14) | Inherited phaeochromocytoma and paraganglioma (id=97, version=1.11) | Inherited phaeochromocytoma and paraganglioma excluding NF1 (id=649, version=2.1) | Inherited renal cancer (id=521, version=1.24) | Multiple endocrine tumours (id=36, version=1.14) | Neuroendocrine cancer pertinent cancer susceptibility (id=183, version=1.4) | Renal cancer pertinent cancer susceptibility (id=154, version=1.2) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Renal cancer (id=3278, version=0.4)",13,TRUE
VTRNA2-1,37054,VTRNA2-1,"Inherited non-medullary thyroid cancer (id=171, version=1.5)",1,FALSE
WAS,12731,WAS,"Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",2,TRUE
WRAP53,25522,WRAP53,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16)",4,TRUE
WRN,12791,WRN,"Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Inherited non-medullary thyroid cancer (id=171, version=1.5) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Thyroid cancer pertinent cancer susceptibility (id=421, version=1.3) | Cancer Predisposition_Paediatric (id=152, version=0.128)",7,TRUE
WT1,12796,WT1,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Adult solid tumours for rare disease (id=391, version=1.36) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Familial rhabdomyosarcoma (id=290, version=1.5) | Sarcoma cancer susceptibility (id=217, version=1.21) | Sarcoma susceptibility (id=734, version=1.73) | Wilms tumour with features suggestive of predisposition (id=1108, version=1.1) | Cancer Predisposition_Paediatric (id=152, version=0.128) | Wilms Tumour Predisposition (id=252, version=0.39)",10,TRUE
XPA,12814,XPA,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
XPC,12816,XPC,"Adult solid tumours cancer susceptibility (id=245, version=2.24) | Childhood solid tumours (id=243, version=4.2) | Childhood solid tumours cancer susceptibility (id=259, version=1.24) | Cancer Predisposition_Paediatric (id=152, version=0.128)",4,TRUE
XRCC2,12829,XRCC2,"Familial breast cancer (id=158, version=1.18) | Haematological malignancies cancer susceptibility (id=59, version=4.2) | Haematological malignancies for rare disease (id=407, version=1.16) | Inherited ovarian cancer (without breast cancer) (id=143, version=4.1)",4,TRUE
